Welcome to LookChem.com Sign In|Join Free

CAS

  • or

122029-28-1

(2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

122029-28-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 122029-28-1 Structure

  • Basic information

    1. Product Name: (2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL
    2. Synonyms: (2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL
    3. CAS NO:122029-28-1
    4. Molecular Formula: C9H11NO5
    5. Molecular Weight: 213.19
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 122029-28-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL(CAS DataBase Reference)
    10. NIST Chemistry Reference: (2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL(122029-28-1)
    11. EPA Substance Registry System: (2-NITRO-3,4-DIMETHOXYPHENYL)METHANOL(122029-28-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 122029-28-1(Hazardous Substances Data)

122029-28-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 122029-28-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,0,2 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 122029-28:
(8*1)+(7*2)+(6*2)+(5*0)+(4*2)+(3*9)+(2*2)+(1*8)=81
81 % 10 = 1
So 122029-28-1 is a valid CAS Registry Number.

122029-28-1Upstream product

122029-28-1Relevant articles and documents

Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety

Feng, Lianshun,Lv, Kai,Liu, Mingliang,Wang, Shuo,Zhao, Jing,You, Xuefu,Li, Sujie,Cao, Jue,Guo, Huiyuan

, p. 125 - 136 (2012/11/07)

A series of novel gemifloxacin (GMFX) derivatives containing a substituted benzyloxime moiety with remarkable improvement in lipophilicity were synthesized. The target compounds evaluated for their in vitro antibacterial activity against representative strains. Our results reveal that most of the target compounds have considerable potency against all of the tested Gram-positive strains including MRSA and MRSE (MIC: 90: 1 μg/mL) is 8-fold more active than GMFX, and 2-fold more active than GMFX and moxifloxacin against MRSE clinical isolates (MIC90: 4 μg/mL). Crown Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 122029-28-1